These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 15682440

  • 1. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y.
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [Abstract] [Full Text] [Related]

  • 2. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma.
    Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Nakaigawa N, Kishida T, Nagashima Y, Kubota Y.
    Clin Cancer Res; 2007 Jan 01; 13(1):152-60. PubMed ID: 17200350
    [Abstract] [Full Text] [Related]

  • 3. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J, Thiesson H, Walter S, Ottosen PD, Skøtt O, Jensen BL.
    Clin Sci (Lond); 2006 Jul 01; 111(1):61-70. PubMed ID: 16515534
    [Abstract] [Full Text] [Related]

  • 4. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K, Komiya A, Hattori K, Huang Y, Sano F, Murakami T, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.
    Clin Cancer Res; 2006 Dec 15; 12(24):7339-46. PubMed ID: 17189405
    [Abstract] [Full Text] [Related]

  • 5. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.
    Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.
    J Cancer Res Clin Oncol; 2008 Dec 15; 134(12):1363-9. PubMed ID: 18483744
    [Abstract] [Full Text] [Related]

  • 6. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A, DiDonato JA.
    BMC Urol; 2004 Jun 22; 4():9. PubMed ID: 15212686
    [Abstract] [Full Text] [Related]

  • 7. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.
    Currie MJ, Gunningham SP, Turner K, Han C, Scott PA, Robinson BA, Chong W, Harris AL, Fox SB.
    J Pathol; 2002 Dec 22; 198(4):502-10. PubMed ID: 12434420
    [Abstract] [Full Text] [Related]

  • 8. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT, Tu JJ, Kao J, Zhou XK, Mazumdar M.
    Clin Cancer Res; 2005 Sep 15; 11(18):6558-66. PubMed ID: 16166433
    [Abstract] [Full Text] [Related]

  • 9. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM, Lu M, Yang P, Wu S, Cai C, Zhong WD, Olumi A, Young RH, Wu CL.
    Hum Pathol; 2015 Jun 15; 46(6):820-6. PubMed ID: 25827535
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J, Ljungberg B, Wikström P, Grankvist K, Lindh G, Rasmuson T.
    Acta Oncol; 2009 Jun 15; 48(6):909-14. PubMed ID: 19322701
    [Abstract] [Full Text] [Related]

  • 11. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
    Tolkach Y, Lüders C, Meller S, Jung K, Stephan C, Kristiansen G.
    Oncotarget; 2017 Apr 25; 8(17):28672-28682. PubMed ID: 28404922
    [Abstract] [Full Text] [Related]

  • 12. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN.
    Arch Pathol Lab Med; 2007 Oct 25; 131(10):1541-6. PubMed ID: 17922590
    [Abstract] [Full Text] [Related]

  • 13. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
    Diegmann J, Junker K, Gerstmayer B, Bosio A, Hindermann W, Rosenhahn J, von Eggeling F.
    Eur J Cancer; 2005 Aug 25; 41(12):1794-801. PubMed ID: 16043348
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
    Cancer Res; 2001 Oct 01; 61(19):7277-81. PubMed ID: 11585766
    [Abstract] [Full Text] [Related]

  • 15. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL.
    Cancer Res; 2005 Jul 15; 65(14):6178-88. PubMed ID: 16024619
    [Abstract] [Full Text] [Related]

  • 16. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y, Murakami T, Sano F, Kondo K, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.
    Eur Urol; 2009 Oct 15; 56(4):690-8. PubMed ID: 18930582
    [Abstract] [Full Text] [Related]

  • 17. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
    Mans DA, Vermaat JS, Weijts BG, van Rooijen E, van Reeuwijk J, Boldt K, Daenen LG, van der Groep P, Rowland BD, Jans JJ, Roepman R, Voest EE, van Diest PJ, Verhaar MC, de Bruin A, Giles RH.
    J Pathol; 2013 Sep 15; 231(1):117-29. PubMed ID: 23744542
    [Abstract] [Full Text] [Related]

  • 18. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
    Lin F, Zhang PL, Yang XJ, Shi J, Blasick T, Han WK, Wang HL, Shen SS, Teh BT, Bonventre JV.
    Am J Surg Pathol; 2007 Mar 15; 31(3):371-81. PubMed ID: 17325478
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S, Tu JJ, Kao J, Mukherjee P, Campagne F, Zhou XK, Hyjek E, Alonso MA, Chen YT.
    Clin Cancer Res; 2006 Dec 01; 12(23):6937-45. PubMed ID: 17145811
    [Abstract] [Full Text] [Related]

  • 20. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA, Bianco FJ, Zhang H, Li X, Sarkar FH, Sakr WA, Grignon DJ, Che M.
    Pathology; 2003 Dec 01; 35(6):513-7. PubMed ID: 14660102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.